| Literature DB >> 35200490 |
Yue Xie1, Pan Gao1, Fangfang He1, Chun Zhang1.
Abstract
Hemorrhage, as a common trauma injury and clinical postoperative complication, may cause serious damage to the body, especially for patients with huge blood loss and coagulation dysfunction. Timely and effective hemostasis and avoidance of bleeding are of great significance for reducing body damage and improving the survival rate and quality of life of patients. Alginate is considered to be an excellent hemostatic polymer-based biomaterial due to its excellent biocompatibility, biodegradability, non-toxicity, non-immunogenicity, easy gelation and easy availability. In recent years, alginate hydrogels have been more and more widely used in the medical field, and a series of hemostatic related products have been developed such as medical dressings, hemostatic needles, transcatheter interventional embolization preparations, microneedles, injectable hydrogels, and hemostatic powders. The development and application prospects are extremely broad. This manuscript reviews the structure, properties and history of alginate, as well as the research progress of alginate hydrogels in clinical applications related to hemostasis. This review also discusses the current limitations and possible future development prospects of alginate hydrogels in hemostatic applications.Entities:
Keywords: alginate; application; hemostasis; hemostatic agent; hydrogel
Year: 2022 PMID: 35200490 PMCID: PMC8871293 DOI: 10.3390/gels8020109
Source DB: PubMed Journal: Gels ISSN: 2310-2861
Figure 1The stylized conformational structure of sodium alginate, including G units, M units and their block patterns and linkages. G, α−L−guluronic acid residue; M, β−D−mannuronic acid residue. The common blocks of G and M units: GG blocks: homopolymer of G units; MM blocks: homopolymer of M units; GM or MG blocks: heteropolymer of G and M or M and G units.
Figure 2The pattern chart of an egg-box structure.
Preparation method of alginate hydrogels.
| Type of Reaction | Materials | Methods Used | Form of Gels | Properties | Ref. |
|---|---|---|---|---|---|
| Ionic cross-linking | Alginate + ZnO | Casting and solvent evaporation | Bi-layered hydrogel films | Antibacterial properties, promotes healing capacity | [ |
| Ionic cross-linking | Alginate + shellac | Microfluidic technology | Amphiphilic hydrogel–solid dimer particles | Amphiphilic structure, biocompatibility | [ |
| Ionic cross-linking | AuNP-CaCO3 + | / | Hydrogel | Fast response, pH-response, and ultrahigh sensitivity | [ |
| Electrostatic interaction and divalent chelation | Alginate + N-carboxymethyl chitosan | / | Dual-crosslinked hydrogels | Tunable mechanical properties, efficient wound closure | [ |
| Hydrogen bonds and Schiff cross-linking | Oxidized sodium alginate + dopamine | / | Hydrogels | Self-healing, high tensile strength and stretchability | [ |
| Molecular entanglements | Alginate + carboxymethylcellulose sodium + chitosan | Thermoforming, high-speed blending | Composite hydrogels | Water vapor permeability | [ |
| Molecular entanglements | Alginate + PVA + PVP | Freezing-thawing method | Hydrogels | Bioadhesive strength and mechanical properties | [ |
| Self-assemble | Alginate + copolymer F127 | / | Hydrogels | Thermo-responsive behavior | [ |
| Guest and host reaction | PEG-Adamantane + β-CD + alginate | / | Hydrogels | Self-healing | [ |
| Photo-cross-linking | Alginate + PVP + chitosan | Gamma-radiation | Hydrogel pads | Photoreactivity, hygroscopicity | [ |
| Ionically cross-linking, covalent cross-linking | laponite + PVA + alginate | Nanohybrid hydrogels | Blood coagulation | [ | |
| Covalent cross-linking, ionically cross-linking | OA + ECM + Amine-rGO | Double-network hydrogel | Improved mechanical properties and electrical conductivity | [ |
Figure 3Reaction formula of modified alginate to obtain its derivatives: (a) Acetylation of alginate using a mixture of pyridine/acetic anhydride. Gel acetylation: M = Ca2+ or TBA+. Acetylation of a homogeneous system in DMSO/TBAF, M = TBA+, M’ = −H or Na+; (b) Phosphorylation of alginates; (c) Sulfation of alginates. The alginate is sulfated with chlorosulfonic acid; (d) Oxidation of sodium alginate; (e) Reductive amination of oxidized sodium alginate.
Figure 4Diagram of the coagulation process. Authorized by John Wiley and Sons Publications, copyright 2020 [80].
Figure 5The gel film layer formed by the hydrogel coating materials at the wound site. They can effectively absorb blood and body fluids, seal the wound, and maintain a suitable healing environment.
Figure 6The illustration exhibits how the hemostatic needles work through the coating. Their syringe needles are topically coated with cross-linking Alginate-CaCl2 hydrogel film coatings, which can swell to form hydrogels during puncture and play a significant role in preventing hemorrhage after puncture.
Figure 7The haemostatic capability of the Alg-Ca-coated needles in viscera puncture. (a) Photographs showing the haemostatic effect produced by Alg-Ca-coated needle (22 G) in rat kidney: bare needle (top) and Alg-Ca-coated needle (bottom). (b) Quantitative analysis of blood loss from rat kidney (n = 8, * p < 0.05) and liver (n = 8, ** p < 0.01). (c) Photographs showing the haemostatic effect of Alg-Ca-coated needle (22 G) in rat liver: bare needle (left) and Alg-Ca-coated needle (right). (d) Cytocompatibility evaluation of the Alg-Ca. [103] Copyright 2020 Elsevier Ltd.
Figure 8The preparation and application process of TACMs.
Figure 9Schematic diagram of the action of injectable hydrogels at the bleeding site. Injectable hydrogels in the form of solutions gel in situ at the wound site under certain conditions, recruit red blood cells and platelets, promote blood coagulation, and achieve the purpose of hemostasis.
Figure 10(A) The chemistry behind the formation of Dopa-OA hydrogel glue. (B,C) The Dopa-OA hydrogel displayed higher tensile strength than OA glue. (D) Hemostatic performance of Dopa-OA glue with respect to OA glue and the control, when used in a mouse liver injury model. Reproduced with permission [128]. Copyright 2019, Springer Nature.
Summary of Different Types of Alginate Materials.
| Type | Materials | Active Ingredients | Properties | Indications | Ref. |
|---|---|---|---|---|---|
| Fibrous dressings | Alginate + nZnO | nZnO | High porosity, antibacterial properties | Severe bleeding and wounds at risk of infection | [ |
| Alginate + chitosan + hyaluronic acid | / | High swelling absorption properties | Moist wound care | [ | |
| Films and membranes | Sodium alginate (SA) + carboxymethyl chitosan (CMCH) | Sr2+, Zn2+ | Cell adhesion enhancement and antibacterial properties | Various stages of wound healing | [ |
| Hyaluronic acid (HA) + sodium alginate (SA) | Sulfadiazine, AgNPs | Mechanical property enhancement, antibacterial properties | Local wound hemostasis and care | [ | |
| Gel-ADH+ SA-mCHO | / | Rapid spray-filming performance | Rapid and massive hemostasis | [ | |
| Sponges | Sodium alginate (SA) + graphene oxide (GO) + polyvinyl alcohol (SPG) | Norfloxacin (NFX) | High water uptake and gas permeability | Hemostasis in superficial wounds, Wound dressings | [ |
| Oxidized cellulose nanocrystals (TOCN) + Sodium alginate (SA) | / | High chemical stability and water absorption | Rapid local hemostasis | [ | |
| Hm-alginate | / | High adhesiveness | Dressing for hemostasis | [ | |
| Hemostatic needles | Alginate + CaCl2 | / | Coating, hemostasis in situ | Prevention of bleeding after vascular and tissue puncture | [ |
| SA + HA + calcium carbonate | CD34 | Coating, hemostasis in situ | Stab wound hemostasis and healing | [ | |
| SA + HA + calcium carbonate | / | Coating, hemostasis in situ | Hemorrhage after AVF or AVG cannulation | [ | |
| Embolic materials | Alginate + CaCl2·2H2O | / | Minimal trauma and good hemostatic effect | Hemostasis in solid visceral organ rupture and hemorrhage | [ |
| Alginate + CaCl2 | Thrombin | Embolic hemostasis | Parenchymal visceral hemorrhage | [ | |
| CaCO3-Alginate | / | High safety and availability | Hepatocellular carcinoma therapy | [ | |
| Injectable Hydrogels | Pept-1 + ALG | Pept-1 | High mechanical strength and hemostatic efficiency | Hemostasis in noncompressible wounds and irregular wounds | [ |
| Oxidized sodium alginate (OA) + dopamine | Dopamine | High stiffness and elasticity | Hemostasis in deep tissue | [ | |
| N-carboxyethyl chitosan + oxidized sodium alginate | CuS-NPs | Injectability and self-healing | Hemostasis of in situ wounds | [ | |
| Hemostatic powders | Carboxymethyl chitosan + sodium alginate + | / | High surface roughness and good biodegradability | Hemostasis in emergency conditions | [ |
| Alginate + silk fibroin | / | High surface roughness | Rapid hemostasis in vitro and in vivo | [ | |
| Alginate + collagen + TF liposomes | Tissue factor (TF) | Efficient and inexpensive, adaptation to various shapes of wounds | Rapid hemostasis in traumatic injury and deep wounds | [ | |
| Microneedles | Alginate + maltose + CaCl2 | Insulin | Excellent mechanical strength and toughness, great swelling and dissolution properties | Sustained release transdermal delivery of insulin | [ |
| Sodium alginate + Bacillus Calmette–Guérin (BCG) | Bacillus Calmette–Guérin (BCG) | Small risk of inducing inflammatory response and skin damage | Transcutaneous immunization with vaccine | [ |